Characterization of in vitro phase I metabolites of methamnetamine in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry

@article{Hong2021CharacterizationOI,
  title={Characterization of in vitro phase I metabolites of methamnetamine in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry},
  author={Young-ki Hong and Young-Hoon Kim and Jin-Moo Lee and Hye Hyun Yoo and Sun Ok Choi and Mi Sun Kang},
  journal={International Journal of Legal Medicine},
  year={2021},
  volume={135},
  pages={1471 - 1476}
}
N-Methyl-1-(naphthalen-2-yl)propan-2-amine (methamnetamine, PAL-1046) is an amphetamine-based new psychoactive substance (NPS). Methamnetamine has been reported to cause excessive release of serotonin, and it is classified as an empathogen or entactogen. It is not regulated as a controlled substance in most countries, and there are no studies on its metabolism. In this study, in vitro phase I metabolism of methamnetamine in human liver microsomes (HLM) and flavin-containing monooxygenase (FMO… 
3 Citations
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions
TLDR
An overview of the metabolic reactions of drugs, natural products, physiological compounds, and other (general) chemicals catalyzed by flavin monooxygenase, monoamine oxidase, NAD(P)H quinone oxidoreductase, and molybdenum hydroxylase enzymes, including roles as substrates, inducers, and inhibitors of the enzymes.
Metabolism testing methods as exemplified by selected new psychoactive substances (NPSs)
TLDR
Alternative methods of metabolism testing for new psychoactive substances (NPSs) are presented and it is shown that by using in vitro methods the metabolism of NPSs can be predicted with high probability.

References

SHOWING 1-10 OF 17 REFERENCES
Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry
TLDR
The in vitro metabolism of 25N-NBOMe was investigated with human liver microsomes, and the reaction mixture was analyzed using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-Q-TOF/MS).
Quantification of Flavin-containing Monooxygenases 1, 3, and 5 in Human Liver Microsomes by UPLC-MRM-Based Targeted Quantitative Proteomics and Its Application to the Study of Ontogeny
TLDR
An ultra-performance liquid chromatography (UPLC)-multiple reaction monitoring (MRM)-based targeted quantitative proteomic method was developed and optimized for the quantification of FMO1, FMO3, and FMO5 in human liver microsomes (HLM).
N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication.
TLDR
Human FMO3-mediated metabolism of amphetamine or methamphetamine may have clinical consequences and the polymorphic nature of N-oxygenation, and the mechanism of product formation were consistent with the production of an N, N-dioxygenated intermediate that lead to phenylpropanone oxime.
Studies of the Biogenic Amine Transporters. XI. Identification of a 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) Analog That Allosterically Modulates the Serotonin Transporter
TLDR
The hypothesis that TB-1-099 allosterically modulates hSERT binding and function is supported.
Studies of the Biogenic Amine Transporters. 14. Identification of Low-Efficacy “Partial” Substrates for the Biogenic Amine Transporters
TLDR
It is concluded that low-efficacy partial DAT substrates promote efflux at a slower rate than full substrates, and “partiality” reflects the ultra-slow K2 constant, which functionally limits the ability of these compounds to increase extracellular DA.
A kinetic account for amphetamine-induced monoamine release
TLDR
A kinetic model was developed, which allowed for random, but cooperative, binding of substrate and Na+ (or K+) and accounted for the releasing action of amphetamines without any digression from alternating access and is the first to provide a mechanistic framework for amphetamine-induced monoamine release.
...
...